IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone

Phillips, L. D., Amzal, B., Asiimwe, A., Chan, E., Chen, C., Hughes, D., Juhaeri, J., Micaleff, A., Mt-Isa, S., Noel, B., +2 more...Shepherd, S. & Wang, N. (2013). IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone. PROTECT Consortium.
Copy
Full text not available from this repository.

Export as

EndNote BibTeX Reference Manager Refer Atom Dublin Core JSON Multiline CSV
Export